Increasing Pretreatment Tumor SUVmean Is Associated With Local Regional Failure After Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
R.S. Rajpara(Emory University), Kristin Higgins(Emory University), Walter J. Curran(Piedmont Cancer Institute), X. Wang(Emory University), Thomas G. Fox(Emory University), Jonathan J. Beitler(Emory University), Liza J. Stapleford(Emory University), Z. Chen(Fudan University), Eduard Schreibmann
International Journal of Radiation Oncology*Biology*Physics
September 20, 2013
Cited by 0
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
|International Journal of Radiation Oncology*Biology*Physics|2007|1k